BSE filing, NSE: JENBURPH. Summary written from the filing by ALFA Finder's alert engine.
Jenburkt Pharmaceuticals Ltd: key numbers
- Share price
- ₹854.00
- Market cap
- ₹376.9 Cr
- Revenue (annual)
- ₹168.7 Cr
- Net profit (annual)
- ₹34.74 Cr
- P/E (TTM)
- 11.5×Sector 45.9×
- Promoter holding
- 46.62%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jenburkt Pharmaceuticals Ltd
All →Jenburkt Pharmaceuticals Board Meeting Date
Jenburkt Pharmaceuticals has intimated that its Board will meet on 3 Nov 2026 to consider Q2/H1-26 financial results. No decision has been taken yet.
Jenburkt Pharmaceuticals Capital Structure Change
Counter Cyclical Investments Private Limited acquired 326 shares of Jenburkt Pharmaceuticals Ltd in the open market, increasing its total shareholding from 4.99% to 5.01%.
Jenburkt Pharmaceuticals Other Announcement
Jenburkt Pharmaceuticals submitted a certificate under SEBI Regulation 74(5) regarding share dematerialization for the quarter ended September 30, 2026.
Jenburkt Pharmaceuticals Other Announcement
Jenburkt Pharmaceuticals clarified its shares are permitted to trade on NSE without a listing application. The shares remain listed on BSE under the Permitted to Trade category.
Jenburkt Pharmaceuticals Management Change
Mr. Vinay Bhatt, Senior Vice President- International Business, has resigned from Jenburkt Pharmaceuticals Limited effective September 18, 2026, due to personal reasons.
Jenburkt Pharmaceuticals Annual General Meeting
Jenburkt Pharmaceuticals held its 41st Annual General Meeting on 4th September, 2026, to discuss financial statements, dividend declaration, and director appointments.
Other financial results announcements
All →Finolex Industries Q2 FY27 Results: Net Profit ₹115 Cr, Down 7.0% YoY
Finolex Industries Ltd reported revenue from operations of ₹1,094 Cr (+27.4% YoY) and net profit of ₹115 Cr (-7.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹115 Cr · -7.0% YoY
Fabtech Cleanrooms H1 FY27 Results: Net Profit ₹5.2 Cr, Up 57.6% YoY
Fabtech Cleanrooms Ltd reported revenue from operations of ₹133.2 Cr (+74.8% YoY) and net profit of ₹5.2 Cr (+57.6% YoY) for H1 FY27.
- Key figure
- Net profit ₹5.2 Cr · +57.6% YoY
IRM Energy Q2 FY27 Results: Net Profit ₹25.4 Cr, Up 101.6% YoY
IRM Energy Ltd reported revenue from operations of ₹363.6 Cr (+29.0% YoY) and net profit of ₹25.4 Cr (+101.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹25.4 Cr · +101.6% YoY
Chemkart India H1 FY27 Results: Net Profit ₹22.6 Cr, Up 121.6% YoY
Chemkart India Ltd reported revenue from operations of ₹205.9 Cr (+99.5% YoY) and net profit of ₹22.6 Cr (+121.6% YoY) for H1 FY27.
- Key figure
- Net profit ₹22.6 Cr · +121.6% YoY
Share India Securities Q2 FY27 Results: Net Profit ₹102.5 Cr, Up 10.0% YoY
Share India Securities Ltd reported revenue from operations of ₹379.5 Cr (+11.3% YoY) and net profit of ₹102.5 Cr (+10.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹102.5 Cr · +10.0% YoY
Pasari Spinning Mills Q2 FY27 Results: Net Profit ₹0 Cr
Pasari Spinning Mills Ltd reported net profit of ₹0 Cr for Q2 FY27.
- Key figure
- Net profit ₹0 Cr